New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
Log in Register
    Chemomab Therapeutics Ltd (CMNB)
    CMNB · NCM · · CUSIP 16385C203
    Last Price•••.••
    Current Yield•.••%
    Yield to Call•.••%
    Yield to Worst•.••%
    Register free Already a member? Log in
    Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CMNB and every other security on QuantumOnline.
    Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒 Advanced Charting 🔒
    🔒
    Price chart and 15 days of daily prices
    Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

    Security Profile

    Security Type
    Common Stock
    CUSIP
    16385C203
    Links: Home Page Investor Relations News
    Business: Chemomab Therapeutics Ltd is a clinical stage biotechnology company developing innovative therapeutics for immune-fibrotic diseases with high unmet need.

    Company Contact

    CEO
    Adi Mor
    CFO
    Sigal Fattal
    Investor Relations
    Barbara Lindheim · 917-355-9234 · barbara.lindheim@chemomab.com
    General Email
    IR@chemomab.com
    SEC EDGAR Filings
    View filings »
    QuantumOnline.com
    Copyright © 1997–2026 QuantumOnline.com. All rights reserved.